Browsing: Amid

ALTERITY THERAPEUTICS LIMITED (ATHE) filed an annual report describing its development-stage neurology business focused on ATH434 for multiple system atrophy (MSA) and other Parkinsonian disorders. ATH434 is the lead and highly concentrated asset; Alterity reported positive FDA feedback and End‑of‑Phase 2 alignment on key elements of a registrational Phase 3 program.

On August 27, 2026, Salesforce Inc CRM released its quarterly 10-Q filing, providing insights into its financial performance and strategic positioning. The company reported total revenues of $11.3 billion for the three months ended July 31, 2026, a notable increase from $10.2 billion in the same period last year. Salesforce continues to lead in the…

On August 27, 2026, Salesforce Inc (NYSE: CRM) saw its shares surge 10% in pre-market trading following the release of its second-quarter fiscal 2027 earnings report, which underscored significant progress in monetizing artificial intelligence capabilities. The company reported its highest net new annual order value growth in four years, driven by expanding Slackbot adoption and…

AVAX One Technology Ltd. (AVX) reported a change in its senior finance leadership. On August 17, 2026, Chief Financial Officer Chris Polimeni resigned from his CFO role and will remain as a financial consultant through December 31, 2026. The company stated his departure was not due to any disagreement regarding operations, policies, or practices and…